The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision on Friday in Apple Inc. v. International Trade ...

Masimo develops advanced noninvasive monitoring technologies used by hospitals and healthcare providers worldwide.

Apple said that it was pleased with the ITC's decision and will evaluate "all avenues for further review" of the Federal ...

A fresh ruling keeps the dispute alive, but Apple’s workaround means the Apple Watch can carry on as usual ...

A US appeals court has found in favor of Masimo in its fight against Apple over pulse oximetry patents, but in the court that matters, a ruling makes it clear that there won't be another ban on the ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q3, starting with Masimo ...

Apple is preparing to appeal a trade ban that forced it to remove the blood oxygen sensor feature from the Apple Watch Series 9 and Ultra 2 models last year. The ban stemmed from a ruling by the ...

Apple is now planning to appeal an infamous ban that led to the Apple Watch Series 9 and Ultra 2 versions losing the blood oxygen sensor feature last year in court. The case saw the International ...

IRVINE, Calif. & RESTON, Va.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a leading medical technology innovator, and Practice Greenhealth, a prominent organization dedicated to advancing sustainability ...

The Stork boot on a baby next to an image of the components of Stork. [Image courtesy of Masimo] Masimo (Nasdaq: MASI) + announced today that the FDA cleared its Stork baby monitoring system for ...